Particulate Respirators Market – Global Industry Analysis 2024Patient suffering from SARS or their surrounding people are the target population for particulate respirators
Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting the nearby surfaces or through airborne transmission. Being a communicable disease, healthcare professionals and medical transport workers are at high risk to such disease as they frequently come in contact with patients suffering from SARS. Hence, Center for Disease Control and Prevention (CDC) has issued interim infection control recommendations for those high risky healthcare centers and facilities. Particulate respirators have proved to be excellent personal protector equipment in order to reduce the risk of inhaling harmful airborne particles. Particulate respirators which has the capability of filtering out 95% of airborne particles are given a 95 rating according to CDC. Likewise, respirators with 99% capability of filtering particles are given a 99 rating and so on.
Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/59
Government initiatives are helping spread awareness among SARS affected victims and helps in fostering market growth
Increasing prevalence of SARS is one of the major drivers impacting the particulate respirators market growth. Moreover, low cost of the product, increasing R&D activities and government initiatives undertaken in order to secure the healthcare professionals from such airborne transmission are some of the factors fueling the demand for particulate respirators. CDC is working with federal agencies, healthcare organizations and local health departments in order to spread awareness among healthcare workers for rapid recognition of person-to-person transmission of SARS. However, lack of proper awareness among people pertaining to the various types of particulate respirators available is hindering the market growth
Disposable respirators are less costly and easy to discard if damaged
On the basis of product, particulate respirators market is segmented into disposable or filtering facepiece respirators, reusable or elastomeric respirators and powered air-purifying respirators. Disposable respirators are for single-use as it gets damaged physically due to excessive resistance and sorbent exhaustion. Reusable respirators are cleaned and reused. However, the filter cartridges are disposed when they become unsuitable for use. Powered air-purifying respirators are usually attached with a battery powered blower which filters the harmful air.
Based on design, particulate respirators are of two types, half face respirators and full face respirators. Particulate respirators are used in hospital settings and also for military, laboratory and other purposes. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Greater awareness levels in North America is enhancing the market growth
North America is one of the high revenue generating market for particulate respirators owing to their growing awareness levels regarding the usage of particulate respirators and increasing R&D activities in this region. Asia Pacific is considered as a lucrative market for growing opportunities of particulate respirators primarily due to the rising prevalence of respiratory disorders in countries like India. The major players are expected to find huge growth opportunities in such countries owing to the rising airborne transmitted diseases.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/particulate-respirators-market-59
3M is one of the leading players of the market based on the performance and sales
Some of the key players for particulate respirators market include 3M Company, The Gerson Company, Drägerwerk AG & Co. KGaA, Honeywell International Inc., MOLDEX and Northern Safety Co., Inc. among others. New product launch is one of the key initiatives undertaken by these companies. For instance, in 2015, 3M launched organic vapor respirator cartridges, which has 3M Service Life Indicator technology that helps to direct the user for an appropriate time to change the cartridges.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.
CORPORATE OFFICE :
Coherent Market Insights
303, Astral Court,Above Reliance Fresh,
Near Gaikwad Petrol Pump,
Aundh, Pune – 411045, India
Mail Id : email@example.com
Visit Blog : http://globalresearchtrends.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Particulate Respirators Market – Global Industry Analysis 2024 here
News-ID: 412316 • Views: 422
More Releases for SARS
Existing Drugs May Inhibit SARS-CoV-2 Virus
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally. The search for effective treatments against the disease are ongoing, and one hurdle is that SARS-CoV-2, the virus that causes COVID-19, has a number of tricks up its molecular sleeve when it comes to infecting people. In a recent study published in Nature Communications Biology, researchers from
Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales Market Report …
In this report, the global Severe Acute Respiratory Syndrome(SARS) Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Severe Acute Respiratory Syndrome(SARS) Therapeutics for these
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 Pharmaceutical Re …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017”. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305521 Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insigh …
Market Research Hub, “Severe Acute Respiratory Syndrome Coronavirus Infection Pipeline Insights”, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection by development stage, therapy type, route of administration
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially